Gene · 34
ACADM: acyl-CoA dehydrogenase medium chain
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. ACADM: acyl-CoA dehydrogenase medium chain. Genes, record 34. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/34
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P11310 | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 421 | 7 | Ensembl, GeneID, HGNC |
Source UniProt
Patents38
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026067851 A | 2026-04-21 | 109 | P11310 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 36260 | P11310 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8853 | P11310 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8853 | P11310 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 1856 | P11310 | Espacenet |
| US 11813258 B2 | 2023-11-14 | 3 | P11310 | Espacenet |
| JP 2023521663 A | 2023-05-25 | 108 | P11310 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 1856 | P11310 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 104827 | P11310 | Espacenet |
| JP 2022519460 A | 2022-03-24 | 27 | P11310 | Espacenet |
1 to 10 of 38
See all 38 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,226
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ACADM papers | Newest fiscal year |
|---|---|---|---|
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 6 | 2025 |
| P30DK056341 | Washington University Nutrition Obesity Research Center | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| P30DK026743 | UCSF Liver Center | 4 | 2025 |
| ZIABC005562 | Xenobiotic receptors | 4 | 2025 |
| ZIABC005708 | Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers | 4 | 2025 |
| P01AI063302 | The intersection of innate and adaptive immunity to intracellular pathogens | 3 | 2025 |
| P30AG028716 | Duke Claude D. Pepper Older Americans Independence Center | 3 | 2025 |
| P30DK020541 | NYR-Diabetes Research Center (NYR-DRC) | 3 | 2025 |
| P30DK052574 | Host-environment interactions in the pathophysiology of digestive disease | 3 | 2025 |
1 to 10 of 1,226Source NIH's project files
See all 1,226 nih grantsPapers1,869
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Medium-chain acyl-CoA dehydrogenase deficiency: A ten-year single-center case series from India. | Clin Chim Acta | 2026 | 42749071 | PubTator, text mining | PubMed |
| When to think of genetic causes for rhabdomyolysis? A Brazilian single-center exploratory study. | Arq Neuropsiquiatr | 2026 | 42595308 | PubTator, text mining | PubMed |
| Medium Chain Acyl-CoA Dehydrogenase Deficiency; an Unexpected Cause of Neonatal Ketoacidosis. | JIMD Rep | 2026 | 42578122 | PubTator, text mining | PubMed |
| Evaluating the potential causal relationship between carnitine-related metabolites and breast cancer: a Mendelian randomization and transcriptomic analysis. | Arch Med Sci | 2026 | 42540481 | PubTator, text mining | PubMed |
| Dynamic regulation of lysine and arginine metabolism promotes immune evasion by limiting T cell function in cancer. | Sci Immunol | 2026 | 42497246 | PubTator, text mining | PubMed |
| Distinct Molecular Signature of Earlobe Keloids: Integrated Transcriptomic Analysis of Extracellualr Matrix, Metalloproteinase, and Metabolic Pathways. | Aesthetic Plast Surg | 2026 | 42414644 | PubTator, text mining | PubMed |
| Mutant KRAS-driven selective mRNA translation reveals mechanisms and therapeutic vulnerabilities in cancer. | Cell Rep | 2026 | 42284146 | PubTator, text mining | PubMed |
| ACADM-mediated fatty acid β-oxidation pathway in atherosclerosis and abdominal aortic aneurysm. | Eur Heart J | 2026 | 42247143 | PubTator, text mining | PubMed |
| Expanding the Utility of Exome Sequencing in Preventive and Population Genetics. | Am J Med Genet A | 2026 | 42212615 | PubTator, text mining | PubMed |
| Identification of 19 Pathogenic Variants in a Clinically Heterogeneous Cohort With Suspected Inborn Errors of Metabolism. | Clin Genet | 2026 | 41968882 | PubTator, text mining | PubMed |
1 to 10 of 1,869
See all 1,869 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/34
GET https://conductscience.org/api/genes/v1/34/patents?page=2